However, decreased levels of PI3K subunits and blunted Akt kinase phosphorylation have been observed in AD brains, which are characterized by amyloid‐β and tau pathologies (Gabbouj et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.